Biomarker study confirms HNL Dimer’s efficacy in monitoring sepsis treatment

The biomarker human neutrophil lipocalin HNL was previously shown to be a useful indicator of bacterial infections. Now, the dimeric form of HNL may also be used to effectively monitor the success of antibiotic treatment in sepsis.

Facebook Comments